|
|
|
|
| Whether you're breaking ground on a brand-new manufacturing facility or looking to upgrade an existing site, there are a dizzying number of considerations. Join Pharmaceutical Online Live on Wednesday, April 16th for a digital panel discussion on key factors in facility design, from construction sequencing to site validation. Registration is free thanks to the support of AES. |
|
|
MARCH'S BEST FEATURED EDITORIAL |
|
|
Trends In FDA FY 2024 Inspection-Based Warning Letters | By Liz Oestreich, Kalah Auchincloss, and Erin Hartmann, Eliquent Life Sciences | Of the 190 warning letters that the FDA issued to drug and biopharma manufacturers in the fiscal year 2024, delve into a deep dive on trends pertinent to the 111 inspection-based letters. |
|
|
|
|
MARCH'S BEST INDUSTRY INSIGHTS |
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|